S-1/A Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2014

Filing Information

Form Type	S-1/A
Accession Number	`0001213900-14-006670`
Period End Date	20140630
Filing Date	20140916
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	relm-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 67 Income Statement 36 Cash Flow Statement 115 Stockholders Equity 34

Balance Sheet 67 line items

Line Item	Tag	Value	Unit	Period
Amortization of deferred financing costs	`AccumulatedAmortizationDeferredFinanceCosts`	-	USD	Point-in-time
Amortization of deferred financing costs	`AccumulatedAmortizationDeferredFinanceCosts`	$69.55K	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$373.00	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.23K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Debt discount	`DebtInstrumentUnamortizedDiscount`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.87K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Debt discount	`DebtInstrumentUnamortizedDiscount`	$141.05K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$178.16K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.32K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Deferred financing costs, net of accumulated amortization of $0 and $69,546 respectively	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Deferred financing costs, net of accumulated amortization of $0 and $69,546 respectively	`DeferredFinanceCostsCurrentNet`	$78.72K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$25.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.61M	USD	Point-in-time
Fixed assets, net of accumulated depreciation of $2,230 and $373, respectively	`PropertyPlantAndEquipmentNet`	$9.84K	USD	Point-in-time
Fixed assets, net of accumulated depreciation of $2,230 and $373, respectively	`PropertyPlantAndEquipmentNet`	$8.50K	USD	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Liquidation Value	`PreferredStockLiquidationPreference`	$0.80	USD	Point-in-time
Liquidation Value	`PreferredStockLiquidationPreference`	$0.80	USD	Point-in-time
Other assets	`OtherAssets`	$12.10K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$25.76M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$3.63M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	40.29M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.96M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.10K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.96M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$180.32K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	40.29M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$382.02K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$438.66K	USD	Point-in-time
Note payable	`ConvertibleNotesPayableCurrent`	$58.36K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$25.59M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$5.09M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$20.10M	USD	Point-in-time
Subordinated promissory notes payable, net of debt discount of $0 and $141,049, respectively	`NotesPayableCurrent`	$758.95K	USD	Point-in-time
Subordinated promissory notes payable, net of debt discount of $0 and $141,049, respectively	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$21.48M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.77M	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$100.00K	USD	Point-in-time
Long-term liability - accrued expense	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$100.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$21.58M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.87M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 40,294,217 and 4,958,778 shares issued and outstanding, respectively	`CommonStockValue`	$40.29K	USD	Point-in-time
Common stock, $0.001 par value, 500,000,000 shares authorized, 40,294,217 and 4,958,778 shares issued and outstanding, respectively	`CommonStockValue`	$4.96K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$16.01M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$54.17M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$33.98M	USD	Point-in-time
Accumulated deficit	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$55.32M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-17.95M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$25.76M	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$3.63M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Revenue	`LicenseAndServicesRevenue`	-	USD	Annual
Revenue	`LicenseAndServicesRevenue`	-	USD	2 Qtrs
Revenue	`LicenseAndServicesRevenue`	-	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$-667.47K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$-5.25M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$-839.96K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-12.11M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$-1.53M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$-2.49M	USD	Annual
Total operating expenses	`OperatingExpenses`	$-3.16M	USD	Annual
Total operating expenses	`OperatingExpenses`	$-12.95M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$-6.77M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.16M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-6.77M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-12.95M	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-3.69M	USD	Annual
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-7.95M	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-12.88M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.41K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	-	USD	Annual
Interest income	`InvestmentIncomeInterest`	$12.75K	USD	Annual
Interest expense	`InterestExpense`	$27.72K	USD	Annual
Interest expense	`InterestExpense`	$220.31K	USD	Annual
Interest expense	`InterestExpense`	$435.61K	USD	2 Qtrs
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-3.70M	USD	Annual
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-13.10M	USD	Annual
Total other (expenses) income	`OtherNonoperatingIncomeExpense`	$-8.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.86M	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.73	USD	2 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.18	USD	Annual
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-3.17	USD	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.43M	shares	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.17M	shares	Annual
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.33M	shares	2 Qtrs

Cash Flow Statement 115 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.86M	USD	Annual
Depreciation expense	`Depreciation`	$373.00	USD	Annual
Depreciation expense	`Depreciation`	$2.33K	USD	2 Qtrs
Depreciation expense	`Depreciation`	-	USD	Annual
Common stock issued for services	`CommonStockIssuedForServices`	$-8.71K	USD	2 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$-3.77M	USD	Annual
Common stock issued for services	`CommonStockIssuedForServices`	$-1.33M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$10.32M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$37.34K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$382.34K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$327.78K	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$118.64K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$69.55K	USD	Annual
Amortization of deferred financing costs	`AmortizationOfFinancingCosts`	$78.72K	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$7.95M	USD	2 Qtrs
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$12.88M	USD	Annual
Loss on change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$3.69M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-160.28K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$182.71K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$89.98K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$32.30K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-57.10K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$565.78K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$369.93K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$315.70K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$4.29K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.58M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.16M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.24M	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$8.87K	USD	Annual
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$3.67K	USD	2 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.87K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-3.67K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.49M	USD	Annual
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	2 Qtrs
Proceeds from sale of Series A preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$3.22M	USD	Annual
Proceeds from sale of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Proceeds from sale of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$22.23M	USD	2 Qtrs
Proceeds from sale of common stock and warrants	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Proceeds from sales of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sales of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	$2.00M	USD	2 Qtrs
Proceeds from sales of common and Class A Series A preferred stock, pursuant to Share Exchange	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Payment of notes payable	`RepaymentsOfNotesPayable`	$19.49K	USD	2 Qtrs
Payment of notes payable	`RepaymentsOfNotesPayable`	$39.99K	USD	Annual
Payment of notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$501.60K	USD	Annual
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	-	USD	2 Qtrs
Proceeds from subordinated promissory notes payable, net of financing costs	`ProceedsFromSubordinatedPromissoryNotesNetOfDeferredFinancingCosts`	$154.90K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.00M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$24.21M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.33M	USD	Annual
Net increase in cash	`CashPeriodIncreaseDecrease`	$1.75M	USD	Annual
Net increase in cash	`CashPeriodIncreaseDecrease`	$1.75M	USD	Annual
Net increase in cash	`CashPeriodIncreaseDecrease`	$22.04M	USD	2 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$21.87K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$3.52M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$21.87K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.77M	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$25.56M	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	Annual
Income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	-	USD	Annual
Interest	`InterestPaid`	$1.10K	USD	2 Qtrs
Conversion of Series A Preferred Stock and Subordinated Notes to common stock	`ShareExchangeOfSubordinatedDebt`	-	USD	Annual
Conversion of Series A Preferred Stock and Subordinated Notes to common stock	`ShareExchangeOfSubordinatedDebt`	-	USD	Annual
Conversion of Series A Preferred Stock and Subordinated Notes to common stock	`ShareExchangeOfSubordinatedDebt`	$900.00K	USD	2 Qtrs
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	-	USD	Annual
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	-	USD	Annual
Conversion of accrued interest to common stock	`ShareExchangeOfAccruedInterest`	$60.92K	USD	2 Qtrs
Note payable issued in connection with director and officer insurance policy	`IssuanceOfDebtInConnectionWithCompensationPolicy`	$77.85K	USD	2 Qtrs
Note payable issued in connection with director and officer insurance policy	`IssuanceOfDebtInConnectionWithCompensationPolicy`	-	USD	Annual
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	-	USD	Annual
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	-	USD	Annual
Fair value of derivative reclassified to additional paid-in-capital in connection with Share Exchange	`FairValueOfDerivativesTerminatedInConnectionWithShareExchange`	$6.80M	USD	2 Qtrs
Fair value of warrant derivatives issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	-	USD	Annual
Fair value of warrant derivatives issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	-	USD	Annual
Fair value of warrant derivatives issued with units offering	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfCommonStock`	$4.33M	USD	2 Qtrs
Beneficial conversion feature	`BeneficialConversionFeature`	-	USD	Annual
Beneficial conversion feature	`BeneficialConversionFeature`	-	USD	Annual
Beneficial conversion feature	`BeneficialConversionFeature`	$186.73K	USD	2 Qtrs
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	-	USD	2 Qtrs
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$984.47K	USD	Annual
Fair value of derivatives issued in connection with issuance of preferred stock	`FairValueOfDerivativesIssuedInConnectionWithIssuanceOfPreferredStock`	$1.76M	USD	Annual
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	-	USD	2 Qtrs
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$26.32K	USD	Annual
Fair value of derivative warrants issued to lenders in connection with issuance of subordinated promissory notes	`FairValueOfDerivativeWarrantsIssuedToLendersInConnectionWithIssuanceOfSubordinatedPromissoryNotes`	$83.36K	USD	Annual
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	$41.68K	USD	Annual
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Fair value of warrants issued in connection with deferred financing costs	`FairValueAdjustmentOfWarrants`	$13.09K	USD	Annual
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$248.66K	USD	Annual
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	$79.61K	USD	Annual
Fair value of derivative warrants issued for offering costs in connection with the issuance of Series A preferred stock	`FairValueOfDerivativeWarrantsIssuedForOfferingCostsInConnectionWithTheIssuanceOfSeriesAPreferredStock`	-	USD	2 Qtrs
Fair value of derivative issued to Wonpung for services	`FairValueOfDerivativeIssuedToWonpungForServices`	-	USD	2 Qtrs
Fair value of derivative issued to Wonpung for services	`FairValueOfDerivativeIssuedToWonpungForServices`	$299.14K	USD	Annual
Fair value of derivative issued to Wonpung for services	`FairValueOfDerivativeIssuedToWonpungForServices`	-	USD	Annual
Exchange of loans and accrued interest for common stock from founder	`ExchangeOfLoansAndAccruedInterestForCommonStockFromFounder`	$1.22M	USD	Annual
Exchange of loans and accrued interest for common stock from founder	`ExchangeOfLoansAndAccruedInterestForCommonStockFromFounder`	-	USD	2 Qtrs
Exchange of loans and accrued interest for common stock from founder	`ExchangeOfLoansAndAccruedInterestForCommonStockFromFounder`	-	USD	Annual
Exchange of subordinated notes and accrued interest for Series A preferred stock	`ExchangeOfSubordinatedNotesAndAccruedInterestForSeriesAPreferredStock`	$1.54M	USD	Annual
Exchange of subordinated notes and accrued interest for Series A preferred stock	`ExchangeOfSubordinatedNotesAndAccruedInterestForSeriesAPreferredStock`	-	USD	Annual
Exchange of subordinated notes and accrued interest for Series A preferred stock	`ExchangeOfSubordinatedNotesAndAccruedInterestForSeriesAPreferredStock`	-	USD	2 Qtrs
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	-	USD	Annual
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	$54.14K	USD	Annual
Cashless exercise of warrants for common stock	`CashlessExerciseOfWarrantsForCommonStock`	-	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$-17.95M	USD	Point-in-time
Issuance of common stock and warrants to a related party for liabilities	`IssuanceOfStockAndWarrantsToARelatedPartyForLiabilitiesValue`	$869.27K	USD	Annual
Forgiveness of liabilities by founder	`DebtInstrumentDecreaseForgiveness`	$353.25K	USD	Annual
Issuance of Series A preferred stock for conversion of loans and accrued interest	`StockIssuedDuringPeriodValueIssuedForConversionOfLoansAndAccruedInterest`	$1.54M	USD	Annual
Issuance of common stock for cashless exercise of warrants	`StockIssuedDuringPeriodValueIssuedForCashlessExerciseOfWarrants`	-	USD	Annual
Issuance of common stock for cashless exercise of warrants, Shares	`StockIssuedDuringPeriodSharesIssuedForCashlessExerciseOfWarrants`	618,766.00	shares	Point-in-time
Issuance of common stock to acquire license at fair value	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$5.13K	USD	Annual
Issuance of Series A preferred stock to Wonpung for services	`IssuanceOfSeriesAPreferredStockToWonpungForServicesValue`	$1.01M	USD	Annual
Issuance of Series A preferred stock and warrants for cash, net of offering costs	`IssuanceOfSeriesAPreferredStockAndWarrantsForCashNetOfOfferingCostsValue`	$2.16M	USD	Annual
Issuance of Series A preferred stock and warrants for cash, net of offering costs	`IssuanceOfSeriesAPreferredStockAndWarrantsForCashNetOfOfferingCostsValue`	$1.48M	USD	Annual
Issuance of common stock to acquire Medeor, Inc. at fair value	`StockIssuedDuringPeriodValueAcquisitions`	$3.75M	USD	Annual
Issuance of common stock to acquire Medeor, Inc. at fair value, Shares	`StockIssuedDuringPeriodSharesAcquisitions`	17,089.00	shares	Point-in-time
Issuance of common stock, Series A warrants and Series B warrants for cash, net of offering cost	`IssuanceOfCommonStockForSeriesAWarrantsAndSeriesBWarrantsValue`	$22.23M	USD	2 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$16.92K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$8.71K	USD	2 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$20.51K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$10.32M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$37.34K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$382.34K	USD	Annual
Establishing warrant derivative liabilities	`IssuanceOfFairValueOfWarrantDerivativeLiabilitiesIssuedInUnitsOfferingDuringPeriodValue.`	$-4.33M	USD	2 Qtrs
Reclassification of derivative liabilities to APIC upon Share Exchange	`IssuanceOfEliminatingDerivativeLiabilitiesUponShareExchangeDuringPeriodValue`	$6.80M	USD	2 Qtrs
Conversion of Series A preferred stock, notes payable and accrued interest to common stock	`SeriesAPreferredStockNotesAndAccruedInterestForCommonStockAutomaticConversionFeatureValue`	$960.92K	USD	2 Qtrs
Issuance of common stock and Class A preferred stock in connection with share exchange	`IssuanceOfCommonStockAndPreferredStockInConnectionWithShareExchange`	$2.00M	USD	2 Qtrs
Amortization of beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$-186.73K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-19.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-21.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.86M	USD	Annual
Ending Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-1.11M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-3.71M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$-17.95M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.